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Abstract
Background: Associations between ambient temperature and cardiovascular mortality are well established. This
study investigated whether inflammation could be part of the mechanism leading to temperature-related
cardiovascular deaths.
Methods: The study population consisted of a cohort of 673 men with mean age of 74.6 years, living in the
greater Boston area. They were seen for examination roughly every 4 years, and blood samples for inflammation
marker analyses were drawn in 2000-2008 (total of 1254 visits). We used a mixed effects model to estimate the
associations between ambient temperature and a variety of inflammation markers (C-reactive protein, white blood
cell count, soluble Vascular Cell Adhesion Molecule-1, soluble Intercellular Adhesion Molecule-1, tumor necrosis
factor alpha, and interleukins -1b, -6 and -8). Random intercept for each subject and several possible confounders,
including combustion-related air pollution and ozone, were used in the models.
Results: We found a 0 to 1 day lagged and up to 4 weeks cumulative responses in C-reactive protein in
association with temperature. We observed a 24.9% increase [95% Confidence interval (CI): 7.36, 45.2] in C-reactive
protein for a 5°C decrease in the 4 weeks’ moving average of temperature. We observed similar associations also
between temperature and soluble Intercellular Adhesion Molecule-1 (4.52%, 95% CI: 1.05, 8.10, over 4 weeks’
moving average), and between temperature and soluble Vascular Cell Adhesion Molecule-1 (6.60%, 95% CI: 1.31,
12.2 over 4 weeks’ moving average). Penalized spline models showed no deviation from linearity. There were no
associations between temperature and other inflammation markers.
Conclusions: Cumulative exposure to decreased temperature is associated with an increase in inflammation
marker levels among elderly men. This suggests that inflammation markers are part of intermediate processes,
which may lead to cold-, but not heat-, related cardiovascular deaths.
Background
The association between cardio-respiratory mortality
and ambient temperature is well known. More recently,
associations have been found especially between mortal-
ity and heat wave episodes [1-3], but also between mor-
tality and exposure to cold [4-6]. Additional adverse
health effects by temperature may occur due to the cur-
rent increase in the temperature variability caused by
global warming [7,8]. However, the mechanisms under-
lying the temperature-related deaths, and the possibility
to use markers of inflammation as biomarkers of these
mechanisms, are still poorly understood.
Inflammation and vascular dysfunction are among the
proposed mechanisms advancing cardiovascular events
and atherosclerosis. There is evidence that increased
levels of, for example, white blood cell count, a marker
for inflammation, is a predictor of coronary events [9].
Increases in the levels of more commonly studied
inflammation markers such as C-reactive protein (CRP)
and interleukin 6 (IL-6) have been linked to increased
risk of cardiovascular events [10-12]. Recent findings
also suggest that IL-6 and CRP are more strongly asso-
ciated with fatal rather than nonfatal cardiovascular
events [13]. However, the causality of the association
between CRP and cardiovascular diseases is not undis-
puted as elevated CRP has also been suggested to be a
marker of the extent of atherosclerosis or a marker for * Correspondence: jhalonen@hsph.harvard.edu
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cular disease [14].
Interleukin-6 and 1-beta (IL-1b) belong to the group
of acute phase proteins and are released into circulation
as a response to infections or injuries. Other commonly
known acute phase proteins are interleukin 8 (IL-8), and
tumor necrosis factor alpha (TNFa) [15]. In a review of
inflammatory markers of cardiovascular diseases, Ramos
and co-authors [10] suggested that IL-6 and TNFa may
be more useful than CRP in predicting cardiac risks
among the elderly. Coronary heart disease and conges-
tive heart failure have been linked to TNFa levels
among the elderly [16], and the cascade leading to
development and destabilization of atherosclerotic pla-
ques to IL-1b [17]. Other markers of inflammation that
may predict cardiovascular disease are soluble forms of
intercellular adhesion molecule-1 (sICAM-1) and vascu-
lar cell adhesion molecule-1 (sVCAM-1) [18], which are
interrelated markers of inflammation and endothelial
function. However, the potential for outdoor tempera-
ture to affect the low-grade systemic inflammation as
part of the mechanism leading to cardiovascular mortal-
ity has scarcely been studied. To our knowledge, only
two studies from Europe have evaluated these associa-
tions, using selected inflammatory markers, and they
reported inconsistent findings [19,20]. In addition, in
these studies limited data for the summer time tempera-
tures was available.
W et h e r e f o r es t u d i e dt h ep o s s i b l ea s s o c i a t i o n s
between temperature and inflammation markers using
data for the whole year, but controlling for season. To
do so, we evaluated changes in the levels of high sensi-
tive (hs) CRP, IL-1b,I L - 6 ,I L - 8 ,T N F a,s V C A M - 1 ,
sICAM-1 and white blood cell count (WBC) in associa-
tion with a 5°C decrease in mean ambient temperature.
Methods
Study population
The study population consisted of the Normative Aging
Study cohort of men living in the Greater Boston area.
The cohort was established by the Veterans Administra-
tion in 1963 when men aged 21-80 years, confirmed to
be free of known chronic medical conditions, were
enrolled [21]. Subjects were asked to return for physical
examinations and to complete questionnaires on factors
possibly affecting health every 3-5 years. Covariate data
(weight, height, medication use etc.) was updated at
each visit, and blood samples for the markers of inflam-
mation were drawn during each visit between June 2000
and August 2008 for participants (N = 708) still present-
ing for examination. All subjects provided written
informed consent prior to attending the research, and
this investigation has been approved by the Institutional
Review Boards of Harvard School of Public Health and
Normative Aging Study, Veterans Affairs Boston Health-
care System.
Markers of inflammation
Of the biomarkers used in this study hs CRP, sVCAM-1
and sICAM-1 were assayed at Dr. Nader Rifai’s labora-
tory at Children’s Hospital, Boston, MA. High sensitive
CRP concentrations in the serum were determined
using an immunoturbidimetric assay on the Hitachi 917
analyzer (Roche Diagnostics, Indianapolis, IN), using
reagents and calibrators from Denka Seiken (Niigata,
Japan) [22]. Soluble ICAM-1 and soluble VCAM-1 levels
in plasma were measured by using the Enzyme-Linked
Immunosorbent Assay (ELISA) method (R & D Systems,
Minneapolis, MN), with a sensitivity of 0.35 ng/ml for
sICAM-1, and 2.0 ng/ml for sVCAM-1.
Interleukins -1b,- 6 ,a n d- 8 ,T N F a and WBC were
analyzed at Molecular Epidemiology Laboratory of Har-
vard School of Public Health. Interleukins in serum
samples were determined by Chemiluminescent ELISA
as previously described [23]. TNFa was analyzed with
Luminex xMAP multiplexing technology using the
Luminex® 100/200™ System (Luminex, Austin, TX). This
technology allows for sensitive and accurate measure-
ment of up to 100 analytes simultaneously in 25 μlo f
serum. All samples from each participant were analyzed
in duplicate and in one batch to avoid between-batch
analytical variation. White blood cell count was deter-
mined using a standard automated electrical impedance
hematology analyzer (Coulter Counter Model S-Plus
Series - Coulter Electronics). The performance of the
assays was monitored with standard quality control pro-
cedures including the analysis of blinded pooled
samples.
From the data, we excluded visits with hs CRP levels
that were greater than 10 mg/l because those are gener-
ally considered as clinically significant infectious inflam-
matory states [24]. After excluding these values and all
missing data, we had 673 participants with 1 to 4 clinic
visits resulting in total of 1254 visits (685 and 569 dur-
ing warm (May-September) and cold (October-April)
season, respectively).
Meteorological and Air pollution Measurements
Ambient temperature (°C), relative humidity (%) and
barometric pressure (millibar) measurements were
derived from the Boston Logan Airport weather station
located 8 km from the physical examination site. Con-
tinuous black carbon measurements were performed
using an aethalometer (Magee Scientific, Berkeley, Cali-
fornia) at the Harvard School of Public Health monitor-
ing site, 1 km from the examination site. Ambient
ozone was measured continuously at four monitoring
sites in the Greater Boston area. Monitors were located
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all of them conformed to US Environmental Protection
Agency (EPA) standards. In the analyses we used the
average of the four measurements.
Statistical Analyses
All biomarker levels were log10-transformed to approxi-
mate normal distribution and to stabilize variance. We
used mixed effects models to examine possible associa-
tions between ambient temperature and the levels of
biomarkers. This method takes into account the
weighted effect of repeated measurements. We do note
that the estimated random intercepts for subjects with
only one measurement are noisily estimated; however,
the inferences for the fixed effects, such as temperatures,
are appropriate in these models. Even though this
method is used especially for dependent measures,
mixed models do not require repeated measures for all
subjects.
We adjusted models for ap r i o r ichosen known or
plausible confounders including specific personal and
temporal characteristics. All models included random
effects for subjects and fixed effects for body mass index
(BMI, as a continuous variable), age, cigarette smoking
(never/former/current), alcohol consumption (≥2 drinks/
day: yes/no), use of any antihypertensive medication and
statins (yes/no), diabetes (yes/no), hypertension (yes/no),
fasting blood glucose level (1: < 110 mg/dl, 2: > 110 or
< 126 mg/dl, 3: > 126 mg/dl), race and years of educa-
tion. Models included also indicator variables for season
(warm/cold), weekday, and sine and cosine terms for
day of year to capture seasonality more effectively. Addi-
tionally, the 24-hour means of relative humidity and
barometric pressure were considered as possible con-
founders. The analyses were performed with statistical
software R 2.10.1. using the linear and non-linear mixed
effects models library (nlme) [25].
The effects of temperature on morbidity and mortality
have been seen over lag periods up to 7-25 days [26,27],
but more strongly at shorter lags. Therefore we chose a
priori to analyze single-lag days from 0 to 14, and the
moving averages of 7, 14, 21 and 28 days. Moving aver-
age of 7 days included lag days 0 to 6 prior to the clinic
visit and is referred as “1 week” in tables and figures,
moving average of 14 days included lag days 0 to 13 and
is referred as “2 weeks”, etc.
As secondary analyses, we studied interaction between
temperature and obesity (BMI > 30 at the first visit in
this dataset) to uncover possible effect modification,
because obesity itself is considered as a low-grade
inflammation state [24]. Because diabetes was previously
found to be an effect modifier of the association
between temperature and inflammation in coronary
heart disease patients [20], we studied if the same was
true in our cohort. Furthermore, effect modification by
age has been found in temperature-health associations,
and therefore we studied also interactions between tem-
perature and age. We studied the possible confounding
by combustion-related air pollution by adjusting the
models for black carbon, because increases in the levels
of CRP [28,29], IL-6 [30,31] and sVCAM-1 [32] have
been independently associated with increases in the
levels of combustion-related pollutants. To do so, we
used the same lag for black carbon as for temperature
in the models. The possible confounding effect of ozone
was studied similarly, as exposure to ozone has also
been associated with inflammation [33].
As sensitivity analyses, we inspected the linearity of
the associations between temperature and biomarkers
using plots created by generalized additive mixed model
(gamm) with the mgcv library [34] in R, and we
excluded the 2.5% of the hottest and the coldest days
from the data. Cut offs for the hottest temperatures
were: 27.9°C for lags 0 and 1, and 23.8 - 24.9°C for the
moving averages, and for the coldest temperatures: -4.8°
C for lags 0 and 1, and -1.97 - -4.56°C for the moving
averages. Finally, we performed analyses for lag days 0
and 1 including a covariate for the indoor temperature
of the examination room using a smaller data set (1087
clinical visits for 615 subjects). Less data was available
because indoor temperature was measured for a shorter
time period than the inflammation markers.
Results
The mean (sd) ambient temperature over the study per-
iod was 12.4°C (9.0), and the indoor temperature for the
measured period was 23.8°C (1.6). We used only one
temperature measurement site for our analyses. How-
ever, the correlation between temperatures at Boston
Logan Airport and T.F. Green Airport (Warwick, RI),
that is a closer site to the study subjects living the furth-
est from Boston, was 0.96 (mean distance of the address
of participants from airport was 18 km). This suggests
that there is little variation in the temperature over the
study area. Summary statistics of the environmental
variables is in Table 1.
The age of the study subjects was within the range of
55-100 years, and 26.1% of them were obese (n = 176),
Table 1 Summary statistics of the environmental
variables
Variable Min Mean (sd) Max
Ambient Temperature (°C) -13.9 12.4 (9.0) 31.7
Relative Humidity (%) 26.6 67.9 (15.7) 99.3
Barometric pressure (mbar) 983.6 1016.0 (7.9) 1036.0
Black Carbon (μg/m
3) 0.12 0.84 (0.44) 2.7
O3 (ppb) 3.37 23.6 (12.3) 85.1
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subjects, 245 had only one clinic visit, 276 had two vis-
its, 151 had three visits, and one had four visits. More
complete summarization of the study subjects’ charac-
teristics is provided in Table 2. Spearman rank correla-
tions between temperature, inflammation markers and
the pollutants are provided in the additional file 1. All
results are presented as a % change in the biomarker
level for a 5°C decrease in temperature with 95% Confi-
d e n c eI n t e r v a l( C I ) .T h ed e c r e a s eo ff i v ed e g r e e sw a s
chosen because this is within the range of daily tem-
perature variation in the study area.
We found positive associations between decrease in
ambient temperature and the levels of hs CRP, sICAM-1
and sVCAM-1 throughout all investigated lags (Figure 1).
Significant associations between temperature and hs CRP
were observed with acute, 0 to 1 day, and cumulative lags
(Table 3). To study whether the acute and cumulative
effects were independent of each other, we run models
including lag 0 or lag 1 with the 4 weeks’ moving average
for the temperature. The correlation between tempera-
ture on the current day and the 4 week’sm o v i n ga v e r a g e
was 0.88, and between lag day 1 and 4 week’sm o v i n g
average 0.90. All effect estimates were slightly reduced in
the two-lag models, possibly due to rather high correla-
tion between temperatures. However, the associations at
lags 0 and 1 were still borderline significant and the asso-
ciation over the 4 weeks’ moving average remained sig-
nificant (20.0%, 95% CI: 2.65, 40.2, when analyzed with
lag 0). Associations between temperature and adhesion
molecules sVCAM-1 and sICAM-1 were the strongest
o v e rt h ec u m u l a t i v el a g s( T a b l e3 ) .W ed i dn o tf i n ds i g -
nificant associations for the other inflammation markers
(See additional files 2 and 3).
When we adjusted the model of hs CRP for black car-
bon we observed little changes in the associations
between temperature and hs CRP, but adjusting for O3
made the associations slightly stronger (Table 3). The
associations between temperature and adhesion mole-
cules became slightly stronger after adjustment for black
carbon, but remained similart oo r i g i n a lm o d e la f t e r
adjustment for O3 (Table 3). We found no interactions
between temperature and obesity, diabetes or age.
Adjusting the models for room temperature had
minor effects on the effect estimates for 0 and 1-day
lags (Additional file 4). As a test of the linearity assump-
tion, we fit penalized splines for temperature using a
gamm when the software chose the optimized degrees
of freedom for temperature using generalized cross vali-
dation. This was 1 degree of freedom for hs CRP and
sICAM-1 when using the moving average of tempera-
ture over 4 weeks, suggesting that the effects were lin-
ear. When we excluded the extreme temperatures (32
cold and 22 hot days excluded, total of 1190 observa-
t i o n su s e di nt h ea n a l y s i s )f r o mt h ed a t a ,t h eo b s e r v e d
associations at the cumulative lags became slightly
stronger (Table 4).
Discussion
In the present study, we found an increase in the levels
of three inflammation makers; hs CRP, sICAM-1, and
sVCAM-1, in association with a 5°C decrease in ambient
temperature. We found no evidence of associations
between temperature and other markers of inflamma-
tion. These findings suggest that some of the inflamma-
tion markers could be used as biomarkers of the
Table 2 Descriptive statistics of the individual
characteristics of the study subjects
Variable Mean (sd)
C-reactive protein (mg/l) 2.3 (2.1)
White blood cell count (1000/mm
3) 6.4 (3.0)
Interleukin 1 beta (pg/ml) 33.0 (123.9)
Interleukin 6 (pg/ml) 172.5 (351.4)
Interleukin 8 (pg/ml) 75.9 (84.2)
Soluble Vascular Cell Adhesion Molecule (ng/ml) 1066 (400.0)
Soluble Intercellular Adhesion Molecule (ng/ml) 299.0 (77.2)
Tumor necrosis factor alpha (pg/ml) 60.0 (199.2)
Age (years) 74.6 (6.6)
Body mass index (kg/m
2) 28.1 (4.2)
Education (years) 14.6 (2.8)
N subjects (%)
Obese (Body mass index > 30) 176 (26.1)
Use of statins 378 (56.2)
Use of any antihypertensive medication 483 (71.8)
Diabetes 114 (17.0)
Hypertension 542 (80.5)
Race
Non-Hispanic white 649 (96.4)
Non-Hispanic black 12 (1.8)
Hispanic white 9 (1.3)
Hispanic black 3 (0.4)
Weekday of the visit N observations (%)
Tuesday 363 (28.9)
Wednesday 741 (59.1)
Thursday 150 (11.9)
Smoking status
Never 368 (29.3)
Former 840 (67.0)
Current 46 (0.4)
Fasting blood glucose
< 110 mg/dl 906 (72.2)
> 110 or < 126 mg/dl 202 (16.1)
> 126 mg/dl 146 (11.6)
Alcohol intake(≥ 2 drinks/day) 236 (18.8)
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Page 4 of 9Figure 1 The % change in inflammation markers for a 5°C decrease in temperature. The % change (95% confidence intervals) in high
sensitive C-reactive protein, soluble intercellular adhesion molecule-1, and soluble vascular cell adhesion molecule-1 in association with a 5°C
decrease in ambient temperature.
Table 3 The % change in the levels of hs CRP, soluble VCAM-1, and soluble ICAM-1 for a 5°C decrease in ambient
temperature
Original model
a Adjusted for BC
b Adjusted for O3
c
% Change 95% CI % Change 95% CI % Change 95% CI
hs C-reactive protein
Lag 0 8.02 * 1.93, 14.8 7.03 * 0.60, 13.9 9.39 * 2.97, 16.2
Lag 1 8.18 * 1.57, 15.2 10.0 * 3.09, 17.4 9.26 * 2.63, 16.6
1 week 10.2 * 0.51, 20.8 10.1 -0.12, 21.3 12.6 * 2.41, 23.8
2 weeks 16.7 * 4.05, 30.8 15.0 * 2.06, 29.6 19.2 * 6.11, 34.0
3 weeks 22.1 * 6.89, 39.6 19.7 * 4.12, 37.6 23.3 * 7.72, 41.0
4 weeks 24.9 * 7.36, 45.2 23.4 * 5.53, 44.2 26.3 * 8.50, 47.0
Soluble vascular cell adhesion molecule-1
Lag 0 -0.94 -2.68, 1.02 0.41 -1.66, 2.52 -0.48 -2.49, 1.57
Lag 1 0.77 -1.36, 2.94 1.57 -0.62, 3.82 0.63 -1.56, 2.88
1 week 1.44 -1.66, 4.64 2.49 -0.82, 5.91 0.64 -2.52, 3.91
2 weeks 3.80 -0.13, 7.89 4.96 * 0.18, 9.28 2.82 -1.15, 6.95
3 weeks 4.41 -0.19, 9.22 5.70 * 0.84, 10.8 3.71 -0.89, 8.53
4 weeks 6.60 * 1.31, 12.2 8.04 * 2.51, 13.9 5.83 * 0.56, 11.4
Soluble intercellular adhesion molecule-1
Lag 0 0.79 -0.51, 2.10 0.71 -0.68, 2.11 1.31 -0.01, 2.71
Lag 1 0.02 -1.39, 1.44 -0.08 -1.53, 1.39 0.32 -1.12, 1.79
1 week 0.31 -1.74, 2.40 0.91 -1.26, 3.13 0.22 -1.88, 2.36
2 weeks 1.82 -0.76, 4.47 2.95 * 0.23, 5.74 1.41 -1.21, 4.10
3 weeks 2.91 -0.12, 6.04 4.64 * 1.42, 7.92 2.59 -0.45, 5.72
4 weeks 4.52 * 1.05, 8.10 6.42 * 2.79, 10.2 4.23 * 0.76, 7.82
* P-value < 0.05
a Model adjusted for relative humidity, barometric pressure, season, time trend, weekday, age, smoking, use of any anti-hypertensive medication and statins,
body mass index, hypertension, education, diabetes, alcohol use (≥ 2 drinks/day), and race
b Model adjusted for black carbon, relative humidity, barometric pressure, season, time trend, weekday, age, smoking, use of any antihypertensive medication
and statins, body mass index, hypertension, education, diabetes, alcohol use (≥ 2 drinks/day), and race
c Model adjusted for ozone, relative humidity, barometric pressure, season, time trend, weekday, age, smoking, use of any antihypertensive medication and
statins, body mass index, hypertension, education, diabetes, alcohol use (≥ 2 drinks/day), and race
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ity related to exposure to decreasing temperatures.
We found acute and cumulative effects of temperature
on hs CPR levels, the most commonly used marker for
low-grade inflammation for predicting changes in cardi-
ovascular health. In both cases, the levels of hs CRP
increased linearly in association with decreasing tem-
perature, and the effects were independent of each
other. The acute effects are biologically plausible since
serum levels of CRP can increase rapidly, reaching the
level of 5 mg/l in six hours [35]. The cumulative effects
can indicate an ongoing inflammation triggered by
repeated exposures to decreasing temperatures. Cumula-
tive effects may also be present because the recovery
from illnesses and inflammation among the elderly may
be slow. When the extreme temperatures were excluded,
the associations became slightly stronger for the cumu-
lative lag, providing further support for our findings.
The direction of the association we found is consistent
with the findings of a multi-city panel study of myocar-
dial infarction survivors in Europe, where decrease in
temperature predicted increase in the levels of CRP [19].
The data in that study; however, was mainly from the
cold season including only one city with measurements
also for the whole summer, which may have resulted in
underestimation of the effects of warmer temperatures.
Contradictory findings for winter season in Germany
have been recently reported by Hampel et al. [20], who
found a decrease in hs CPR levels in association with
decrease in temperature among men with coronary
heart disease. The contradictory in the findings may be
related to different study populations, as Hampel et al.
studied individuals diagnosed with cardiovascular or
pulmonary disease.
The effects of temperature on adhesion molecule levels
have been evaluated only once before, and only for the
cold season in the study by Hampel et al. [20]. The
authors observed a 5-day cumulative increase of 4.6%
(95% CI, 0.2, 9.1%) in sICAM-1 for a 10°C decrease in
temperature among men with coronary heart disease. The
direction of the association is again consistent with our
results, but the time lag in which the association was most
prominent in the current study was longer; 3 to 4 weeks,
while the association over the 7-day moving average was
positive but not significant. We found similar associations
between temperature and sVCAM-1 to those between
temperature and sICAM-1. Similarity of these findings
was expected due to moderate correlation (0.40) between
sICAM-1 and sVCAM-1, even though higher short-term
reactivity of ICAM-1 than VCAM-1 after exposure to exo-
genous factors has been reported in cell studies [36].
Current and previous [19] findings suggest a linear asso-
ciation between temperature and inflammatory markers,
which is only partly consistent with the proposed U- and
V-shaped associations between temperature and cardio-
vascular mortality [5,37,38]. Results from the study by
Schneider and co-authors [19] seem to reflect the left part
of the U- or V-shaped association between temperature
and mortality, and therefore suggesting that inflammation
may have a role in cold-related cardiovascular deaths. Our
finding of an increase in the levels of inflammation mar-
kers in association with decreasing temperature, control-
ling for season, also suggests that inflammation may be
part of the intermediate processes leading to cardiovascu-
lar mortality related to decreasing, but not increasing, tem-
perature. While not consistent with the majority of the
mortality studies, our findings are in line with recent find-
ings where an inverse association between temperature
and myocardial infarction mortality in summer was
reported [6]. Our results could also reflect the finding that
in the U.S. there has been a decline in heat-related cardio-
vascular deaths during recent years, whereas the effects of
cold temperature have persisted [39]. There is also similar-
ity in the time lags in which the associations are observed
for biomarkers and mortality. In this study, the
Table 4 The % change in the levels of hs CRP, soluble
VCAM-1, and soluble ICAM-1 for a 5°C decrease in
ambient temperature excluding the extreme
temperatures
2.5% Hottest and coldest excluded
% Change 95% CI
C-reactive protein
Lag 0 7.16 * 0.33, 14.5
Lag 1 4.41 -2.61, 11.9
1 week 1.69 -8.29, 12.7
2 weeks 8.26 -4.84, 23.1
3 weeks 20.5 * 3.51, 40.2
4 weeks 29.2 * 2.93, 45.1
Soluble vascular cell adhesion molecule-1
Lag 0 -1.00 -3.16, 1.20
Lag 1 0.92 -1.41, 3.32
1 week 1.37 -1.14, 7.82
2 weeks 3.24 -2.45, 8.99
3 weeks 3.35 -1.77, 8.85
4 weeks 6.70 * 0.75, 13.0
Soluble intercellular adhesion molecule-1
Lag 0 0.55 -0.92, 2.03
Lag 1 0.41 -1.14, 1.98
1 week 0.77 -1.53, 3.12
2 weeks 1.72 -1.17, 4.70
3 weeks 3.84 * 0.45, 7.34
4 weeks 6.01 * 2.10, 10.1
* P-value < 0.05
a Model adjusted for relative humidity, barometric pressure, season, time
trend, weekday, age, smoking, use of any anti-hypertensive medication and
statins, body mass index, hypertension, education, diabetes, alcohol use (≥ 2
drinks/day), and race
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associations between low temperature and mortality have
been reported to occur up to 14 to 25 days after exposure
[26,27]. Nevertheless, more research using different study
populations and at different locations is needed to confirm
our findings.
An association between CRP and particles from traffic
has recently been reported [28], but in our study, black
carbon, a marker of combustion-related air pollution, did
not confound the association between temperature and
hs CRP. We observed minor confounding by black car-
bon, with additive effects, when we analyzed associations
between temperature and adhesion molecules. A pre-
vious study on our study cohort found an association
between black carbon and sVCAM-1 with 2 days delay
[32], and the current results suggest that more cumula-
tive associations between black carbon and adhesion
molecules may also exist. Ozone is a reactive gas that has
been linked to increase in CRP in one study [33], but not
in others [40,41]. We found minor confounding effect by
ozone, which lead to strengthening of the association
between temperature and hs CRP. However, ozone did
not confound the associations between temperature and
adhesion molecules. We did not observe effect modifica-
tion by obesity in this study, even though obesity itself
may lead to low-grade inflammatory state, because adi-
pose tissue is able to produce inflammatory cytokines
[42]. In addition, we did not find effect modification by
diabetes, as was reported in a previous study [20].
We studied a cohort of elderly individuals, who have
been found to be a vulnerable subgroup with regard to
low temperatures [43]. Because climate change intro-
duces greater variability in temperature, it would be rea-
sonable to take proactive actions against cold and
sudden changes in weather. For example, adequate
clothing, and good insulation and proper indoor heating
of the residences of the elderly should be provided. Doc-
tors could also recommend their cardiac patients and
the elderly to follow weather forecasts in order to get
prepared for changes in temperature.
Our study was subject to some limitations. The study
population was homogenous including only elderly men
living within a geographically limited area, so one should
be cautious about making extrapolations of these results
to other population groups. We did not have data on the
time-activity patterns of the study subjects considering
time spent indoors and outdoors, but we did attempt to
control for the effect of the temperature in the examina-
tion room, which seemed to have little effect on the results
found for acute lags. The previous studies addressed the
same problem of exposure assessment, but it seems plausi-
ble that because cardiovascular mortality is associated with
changes in outdoor temperature, the same can be true for
inflammation markers [19,20]. Additionally, we had
outdoor temperature measurements from only one moni-
toring site, which may not perfectly mirror the exposure
of the whole study population; however, as the correlation
between temperature measurements at two airports 100
km apart was high, the variation in temperature in the
study area can be considered small. In future studies, per-
sonal temperature monitoring should be used to obtain
more accurate exposure variables. Another limitation was
that we could not adjust for the use or availability of air
conditioning even though having central air conditioning
has been shown to explain some of the disparities in heat-
related mortality [44]. It is possible that inability to control
for air conditioning lead to weaker than expected associa-
tions between high temperatures and inflammation mar-
kers. Finally, we did not correct for multiple comparisons
in this study; however, we studied inflammation markers
that have been associated with cardiovascular outcomes in
previous studies [10-12,16-18]. On the other hand, the
s t r e n g t h so fo u rs t u d yi n c l u d e dt h eu s eo fal a r g es t u d y
cohort with more than 1,200 observations without seaso-
nal restrictions, as in previous studies. We also adjusted
the models for a variety of patient characteristics and air
pollution as possible confounders, and included time lags
up to 4 weeks in order to capture more cumulative effects
of temperature.
Conclusions
We found a linear relationship between decrease in out-
door temperature and the levels of hs CRP, sVCAM-1,
and sICAM-1 among elderly men. The associations
were acute and cumulative for hs CRP, but mainly 3 to
4 weeks delayed for the adhesion molecules. Our find-
ings suggest that inflammatory markers can be part of
the intermediate processes that lead to cardiovascular
deaths following exposure to decreasing, but not
increasing, temperatures.
Additional material
Additional file 1: Spearman rank correlations between
environmental variables, air pollution and inflammation markers.
Additional file 2: Associations between temperature and
inflammation markers. The % change (95% confidence intervals) in the
levels of interleukins -1b, -6 and -8 for a 5°C decrease in temperature
among elderly men.
Additional file 3: Associations between temperature and
inflammation markers. The % change (95% confidence intervals) in the
levels of white blood cell count and tumor necrosis factor a for a 5°C
decrease in temperature among elderly men.
Additional file 4: The % change in the inflammation markers for a
5°C decrease in ambient temperature. The % change (95% confidence
intervals) in the levels of C-reactive protein, soluble vascular cell adhesion
molecule-1, and soluble intercellular adhesion molecule-1 in association
with a 5°C decrease in ambient temperature in models adjusted for
room temperature.
Halonen et al. Environmental Health 2010, 9:42
http://www.ehjournal.net/content/9/1/42
Page 7 of 9Acknowledgements
This work was supported by the National Institute of Environmental Health
Sciences grants ES014663, ES15172, and ES-00002, and by U.S. Environmental
Protection Agency grant R83241. The VA Normative Aging Study is
supported by the Cooperative Studies Program/Epidemiology Research and
Information Centers of the U.S. Department of Veterans Affairs and is a
component of the Massachusetts Veterans Epidemiology Research and
Information Center, Boston, Massachusetts. Financial support to Jaana I.
Halonen was also provided by Finnish Cultural Foundation and Finnish
Foundation for Cardiovascular Research. Work for this manuscript was
performed at the Harvard School of Public Health
None of the funding bodies had any role in the study design; in the
collection, analysis, and interpretation of data; in the writing of the
manuscript; or in the decision to submit the manuscript for publication.
Author details
1Department of Environmental Health, Harvard School of Public Health,
Boston, MA, USA.
2School of Public Health and Clinical Nutrition, University
of Kuopio, Kuopio, Finland.
3VA Normative Aging Study, Veterans Affairs
Boston Healthcare System, Boston, MA, USA.
4The Department of Medicine,
Boston University School of Medicine, Boston, MA, USA.
5Harvard School of
Public Health, Landmark Center West, Room 415 E, 401 Park Drive, Boston,
MA 02215, USA.
Authors’ contributions
JIH performed the statistical analyses and drafted the manuscript. AZ helped
with the statistical analyses and helped to draft the manuscript. DS
participated to the organization of the study subjects’ clinical visits and
critically reviewed the draft. PSV participated in coordinating the clinic visits
of the study subjects and reviewed the manuscript. JS conceived and
coordinated the study and helped with the statistical analyses and to draft
the manuscript. All authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 8 April 2010 Accepted: 23 July 2010 Published: 23 July 2010
References
1. Almeida SP, Casimiro E, Calheiros J: Effects of apparent temperature on
daily mortality in Lisbon and Oporto, Portugal. Environ Health 2010,
9(1):12.
2. Le Tertre A, Lefranc A, Eilstein D, Declercq C, Medina S, Blanchard M,
Chardon B, Fabre P, Filleul L, Jusot JF, et al: Impact of the 2003 heatwave
on all-cause mortality in 9 French cities. Epidemiology 2006, 17(1):75-79.
3. Ostro BD, Roth LA, Green RS, Basu R: Estimating the mortality effect of the
July 2006 California heat wave. Environ Res 2009, 109(5):614-619.
4. McMichael AJ, Wilkinson P, Kovats RS, Pattenden S, Hajat S, Armstrong B,
Vajanapoom N, Niciu EM, Mahomed H, Kingkeow C, et al: International
study of temperature, heat and urban mortality: the ‘ISOTHURM’ project.
Int J Epidemiol 2008, 37(5):1121-1131.
5. Medina-Ramon M, Schwartz J: Temperature, Temperature Extremes, and
Mortality: A Study of Acclimatization and Effect Modification in 50
United States Cities. Occup Environ Med 2007, 64:827-833.
6. Wolf K, Schneider A, Breitner S, von Klot S, Meisinger C, Cyrys J, Hymer H,
Wichmann HE, Peters A: Air temperature and the occurrence of
myocardial infarction in Augsburg, Germany. Circulation 2009,
120(9):735-742.
7. Greenough G, McGeehin M, Bernard SM, Trtanj J, Riad J, Engelberg D: The
potential impacts of climate variability and change on health impacts of
extreme weather events in the United States. Environ Health Perspect
2001, 109(Suppl 2):191-198.
8. Intergovernmental Panel on Climate Change: Climate Change 2001: The
Scientific Basis: Contribution of Working Group I to the Third
Assessment Report 1-944. Cambridge 2001.
9. Li C, Engstrom G, Hedblad B: The potential impacts of climate variability
and change on health impacts of extreme weather events in the United
States. Atherosclerosis 2010, 209(2):545-50.
10. Ramos AM, Pellanda LC, Gus I, Portal VL: Inflammatory markers of
cardiovascular disease in the elderly. Arq Bras Cardiol 2009, 92(3):221-
228-227-234.
11. McDermott MM, Lloyd-Jones DM: The role of biomarkers and genetics in
peripheral arterial disease. J Am Coll Cardiol 2009, 54(14):1228-1237.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH:
Inflammation, aspirin, and the risk of cardiovascular disease in
apparently healthy men. N Engl J Med 1997, 336(14):973-979.
13. Sattar N, Murray HM, Welsh P, Blauw GJ, Buckley BM, Cobbe S, de Craen AJ,
Lowe GD, Jukema JW, Macfarlane PW, et al: Are markers of inflammation
more strongly associated with risk for fatal than for nonfatal vascular
events? PLoS Med 2009, 6(6):e1000099.
14. Nordestgaard BG, Zacho J: Lipids, atherosclerosis and CVD risk: is CRP an
innocent bystander? Nutr Metab Cardiovasc Dis 2009, 8:521-524.
15. Koj A: Initiation of acute phase response and synthesis of cytokines.
Biochim Biophys Acta 1996, 1317(2):84-94.
16. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-
Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, et al: Inflammatory
markers and onset of cardiovascular events: results from the Health ABC
study. Circulation 2003, 108(19):2317-2322.
17. Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM:
Interleukin-1 beta in coronary arteries of patients with ischemic heart
disease. Arterioscler Thromb Vasc Biol 1996, 16(8):1000-1006.
18. Ballantyne CM, Entman ML: Soluble adhesion molecules and the search
for biomarkers for atherosclerosis. Circulation 2002, 106(7):766-767.
19. Schneider A, Panagiotakos D, Picciotto S, Katsouyanni K, Lowel H,
Jacquemin B, Lanki T, Stafoggia M, Bellander T, Koenig W, et al: Air
temperature and inflammatory responses in myocardial infarction
survivors. Epidemiology 2008, 19(3):391-400.
20. Hampel R, Breitner S, Ruckerl R, Frampton MW, Koenig W, Phipps RP,
Wichmann HE, Peters A, Schneider A: Air temperature and inflammatory
and coagulation responses in men with coronary or pulmonary diseases
during the winter season. Occup Environ Med 2009.
21. Bell B, Rose C, Damon A: The Normative Aging Study: an interdisciplinary
and longitudinal study of health and aging. Aging Hum Dev 1972, 3:4-17.
22. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J,
Rifai N: Evaluation of nine automated high-sensitivity C-reactive protein
methods: implications for clinical and epidemiological applications. Part
2. Clin Chem 2001, 47(3):418-425.
23. ten Hacken NH, Oosterhoff Y, Kauffman HF, Guevarra L, Satoh T,
Tollerud DJ, Postma DS: Elevated serum interferon-gamma in atopic
asthma correlates with increased airways responsiveness and circadian
peak expiratory flow variation. Eur Respir J 1998, 11(2):312-316.
24. Eklund CM: Proinflammatory cytokines in CRP baseline regulation. Adv
Clin Chem 2009, 48:111-136.
25. Pinheiro JC, Bates DM: Mixed-Effects Models in S and S-Plus. New York:
Springer 2000.
26. Armstrong B: Models for the relationship between ambient temperature
and daily mortality. Epidemiology 2006, 17(6):624-631.
27. Anderson BG, Bell ML: Weather-related mortality: how heat, cold, and
heat waves affect mortality in the United States. Epidemiology 2009,
20(2):205-213.
28. Yue W, Schneider A, Stolzel M, Ruckerl R, Cyrys J, Pan X, Zareba W,
Koenig W, Wichmann HE, Peters A: Ambient source-specific particles are
associated with prolonged repolarization and increased levels of
inflammation in male coronary artery disease patients. Mutat Res 2007,
621(1-2):50-60.
29. Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J,
Heinrich J, Marder V, Frampton M, Wichmann HE, et al: Air pollution and
markers of inflammation and coagulation in patients with coronary
heart disease. Am J Respir Crit Care Med 2006, 173(4):432-441.
30. Delfino RJ, Staimer N, Tjoa T, Gillen DL, Polidori A, Arhami M, Kleinman MT,
Vaziri ND, Longhurst J, Sioutas C: Air pollution exposures and circulating
biomarkers of effect in a susceptible population: clues to potential
causal component mixtures and mechanisms. Environ Health Perspect
2009, 117(8):1232-1238.
31. Panasevich S, Leander K, Rosenlund M, Ljungman P, Bellander T, de Faire U,
Pershagen G, Nyberg F: Associations of long- and short-term air pollution
exposure with markers of inflammation and coagulation in a population
sample. Occup Environ Med 2009, 66(11):747-753.
32. Madrigano J, Baccarelli A, Wright RO, Suh H, Sparrow D, Vokonas PS,
Schwartz J: Air pollution, obesity, genes and cellular adhesion molecules.
Occup Environ Med 2010, 67(5):312-317.
Halonen et al. Environmental Health 2010, 9:42
http://www.ehjournal.net/content/9/1/42
Page 8 of 933. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS: The effect of urban air
pollution on inflammation, oxidative stress, coagulation, and autonomic
dysfunction in young adults. Am J Respir Crit Care Med 2007,
176(4):370-376.
34. Wood SN: Generalized Additive Models: An Introduction with R.
Chapman & Hall/CRC press 2006.
35. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest
2003, 111(12):1805-1812.
36. Apostolov EO, Shah SV, Ok E, Basnakian AG: Carbamylated low-density
lipoprotein induces monocyte adhesion to endothelial cells through
intercellular adhesion molecule-1 and vascular cell adhesion molecule-1.
Arterioscler Thromb Vasc Biol 2007, 27(4):826-832.
37. Curriero FC, Heiner KS, Samet JM, Zeger SL, Strug L, Patz JA: Temperature
and mortality in 11 cities of the eastern United States. American Journal
of Epidemiology 2002, 155(1):80-87.
38. Kunst AE, Looman CWN, Mackenbach JP: Outdoor Air-Temperature and
Mortalty in the Netherlands - A Time-series Analysis. American Journal of
Epidemiology 1993, 137(3):331-341.
39. Barnett AG: Temperature and cardiovascular deaths in the US elderly:
changes over time. Epidemiology 2007, 18(3):369-372.
40. Rudez G, Janssen NA, Kilinc E, Leebeek FW, Gerlofs-Nijland ME, Spronk HM,
ten Cate H, Cassee FR, de Maat MP: Effects of ambient air pollution on
hemostasis and inflammation. Environ Health Perspect 2009,
117(6):995-1001.
41. Steinvil A, Kordova-Biezuner L, Shapira I, Berliner S, Rogowski O: Short-term
exposure to air pollution and inflammation-sensitive biomarkers. Environ
Res 2008, 106(1):51-61.
42. Cancello R, Clement K: Is obesity an inflammatory illness? Role of low-
grade inflammation and macrophage infiltration in human white
adipose tissue. BJOG 2006, 113(10):1141-1147.
43. Keatinge WR, Donaldson GC, Bucher K, Jendritzky G, Cordioli E, Martinelli M,
Katsouyanni K, Kunst AE, McDonald C, Nayha S, et al: Winter mortality in
relation to climate. Int J Circumpolar Health 2000, 59(3-4):154-159.
44. O’Neill MS, Zanobetti A, Schwartz J: Disparities by race in heat-related
mortality in four US cities: the role of air conditioning prevalence.
J Urban Health 2005, 82(2):191-197.
doi:10.1186/1476-069X-9-42
Cite this article as: Halonen et al.: Associations between outdoor
temperature and markers of inflammation: a cohort study. Environmental
Health 2010 9:42.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Halonen et al. Environmental Health 2010, 9:42
http://www.ehjournal.net/content/9/1/42
Page 9 of 9